Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  View Cart Check Out

Country Report

Paediatric Consumer Health in

Paediatric Consumer Health in France

Oct 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

2020 IMPACT

Paediatric vitamins and dietary supplements, nappy (diaper) rash treatments and paediatric acetaminophen all benefit from the outbreak of the COVID-19 virus

The outbreak of COVID-19 is set to benefit sales of paediatric consumer health products, with the landscape moving from value growth of 4% in 2019, to 5% value growth predicted for 2020.

Cough/cold remedies are set to record the sharpest decline in growth as mistrust for the products grows

Paediatric cough, cold and allergy remedies are expected to have the worst performance in 2020, recording a double-digit value decline. These products have already been struggling across the forecast period, due to a mistrust around cold medication, with consumers looking for more natural alternatives for their children.

Bayer Sante Familiale SAS leads the landscape, with Merck Médication Familiale SAS also benefiting from the current climate

Bayer Sante Familiale SAS is set to continue leading the landscape in 2020, with its popular and trusted nappy (diaper) rash cream. Nappy (diaper) rash treatments is expected to see positive results from the outbreak of COVID-19.

Files are delivered directly into your account within a few minutes of purchase.

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

SAMPLES

FAQS ABOUT SAMPLES

Delivery

Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Paediatric Consumer Health industry in France with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Paediatric Consumer Health industry in France, our research will save you time and money while empowering you to make informed, profitable decisions.

The Paediatric Consumer Health in France market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Paediatric Consumer Health in France?
What are the major brands in France?
What are the most popular formats for treatments?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport:

Consumer Health market research database

Want to find out more about this report?

Request more information

Paediatric Consumer Health in France - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Paediatric vitamins and dietary supplements, nappy (diaper) rash treatments and paediatric acetaminophen all benefit from the outbreak of the COVID-19 virus

Cough/cold remedies are set to record the sharpest decline in growth as mistrust for the products grows

Bayer Sante Familiale SAS leads the landscape, with Merck Médication Familiale SAS also benefiting from the current climate

RECOVERY AND OPPORTUNITIES

Following an uplift in sales due to COVID-19, sales are set to decline from 2021; however, growth will remain steady and positive across the forecast period

The landscape will be increasingly challenged by natural alternatives, as OTC options continue to cause concern

Innovation remains limited; however, opportunities exist for paediatric vitamins and dietary supplements

CATEGORY DATA

Table 1 Sales of Paediatric Consumer Health by Category: Value 2015-2020
Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2015-2020
Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2020
Table 4 NBO Company Shares of Paediatric Consumer Health: % Value 2016-2020
Table 5 LBN Brand Shares of Paediatric Consumer Health: % Value 2017-2020
Table 6 Forecast Sales of Paediatric Consumer Health by Category: Value 2020-2025
Table 7 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2020-2025

Consumer Health in France - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 9 Life Expectancy at Birth 2015-2020

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2015-2020
Table 11 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 12 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 13 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
Table 15 Distribution of Consumer Health by Format: % Value 2015-2020
Table 16 Distribution of Consumer Health by Format and Category: % Value 2020
Table 17 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

Summary 1 OTC: Switches 2019-2020

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

Summary 2 Research Sources

Why buy this report?

Want to find out more about this report?

Request more information

Megatrends

Country Report

Paediatric Consumer Health in France

New Report Guarantee

Executive Summary

New Report Guarantee

2020 IMPACT

Paediatric vitamins and dietary supplements, nappy (diaper) rash treatments and paediatric acetaminophen all benefit from the outbreak of the COVID-19 virus

Cough/cold remedies are set to record the sharpest decline in growth as mistrust for the products grows

Bayer Sante Familiale SAS leads the landscape, with Merck Médication Familiale SAS also benefiting from the current climate

Overview

Why buy this report?

SAMPLES

Delivery

Overview

Why buy this report?

Want to find out more about this report?

Table of Contents

Paediatric Consumer Health in France - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Paediatric vitamins and dietary supplements, nappy (diaper) rash treatments and paediatric acetaminophen all benefit from the outbreak of the COVID-19 virus

Cough/cold remedies are set to record the sharpest decline in growth as mistrust for the products grows

Bayer Sante Familiale SAS leads the landscape, with Merck Médication Familiale SAS also benefiting from the current climate

RECOVERY AND OPPORTUNITIES

Following an uplift in sales due to COVID-19, sales are set to decline from 2021; however, growth will remain steady and positive across the forecast period

The landscape will be increasingly challenged by natural alternatives, as OTC options continue to cause concern

Innovation remains limited; however, opportunities exist for paediatric vitamins and dietary supplements

CATEGORY DATA

Consumer Health in France - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Company Reports

Recently Viewed

Complete Catalogue

Country Reports

Company Reports